mounjaro and retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic Mounjaro—but more powerful. The reason comes down to how it works Part 2 — continuing from

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study

Monthly out-of-pocket cost for a Medicare beneficiary, by coverage pathway

Diabetes 63:14221427 Sandoval DA, D'Alessio DA (2015) Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease

A patient reads two headlines on the same day: one drug delivered 24% weight loss in a trial, the other is sitting in a pharmacy fridge right now

Differential effects of glucose-dependent insulinotropic polypeptide receptor/glucagon-like peptide-1 receptor heteromerization on cell signaling when expressed in HEK-293 cells